Edit Entry | Edit CV

Steven Woloshin, MD

Professor of The Dartmouth Institute
Professor of Medicine
Professor of Community and Family Medicine

The Dartmouth Institute
Community and Family Medicine

Dartmouth Medical School, MS 1996
Boston University School of Medicine, MD 1987
Boston University, BA 1987

The Dartmouth Institute for Health Policy and Clinical Practice

Academic Analytics
View Profile

Contact Information

Dartmouth Medical School
HB 7900
Hanover NH 03755

Phone: 603 646 5672
Email: steven.woloshin@dartmouth.edu

Professional Interests

Dr. Woloshin's research interest is in learning how to enhance the quality of medical communication to the public, patients, physicians and policymakers. His work (in collaboration with Dr. Lisa Schwartz) has 2 main approaches: improving the quality of messages presenting health information to people, and preparing audiences to make sense of the messages they receive. His main focus is on the communication of medical statistics and information about the benefits and harms of screening and prescription drugs.

Selected Publications


Physicians' Perspectives On FDA Regulation Of Drugs And Medical Devices: A National Survey.
Dhruva SS, Kesselheim AS, Woloshin S, Ji RZ, Lu Z, Darrow JJ, Redberg RF
Health Aff (Millwood). 2024 Jan;43(1):27-35. doi: 10.1377/hlthaff.2023.00466.
PMID: 38190596

The New USPSTF Mammography Recommendations - A Dissenting View.
Woloshin S, Jorgensen KJ, Hwang S, Welch HG
N Engl J Med. 2023 Sep 21;389(12):1061-1064. doi: 10.1056/NEJMp2307229. Epub 2023 Sep 16.
PMID: 37721382

Overdiagnosis and too much medicine in a world of crises.
Kuhlein T, Macdonald H, Kramer B, Johansson M, Woloshin S, McCaffery K, Brodersen JB, Copp T, Jorgensen KJ, Moller A, Scherer M, Scientific Committee of the Preventing Overdiagnosis Conference
BMJ. 2023 Aug 12;382:1865. doi: 10.1136/bmj.p1865. Epub 2023 Aug 12.
PMID: 37573032

Updating the Know Your Chances Website to Include Smoking Status as a Risk Factor for Mortality Estimates.
Woloshin S, Landsman V, Miller DG, Byrne J, Graubard BI, Feuer EJ
JAMA Netw Open. 2023 Jun 1;6(6):e2317351. doi: 10.1001/jamanetworkopen.2023.17351. Epub 2023 Jun 1.
PMID: 37289457

Physician Perspectives on the Food and Drug Administration's Decision to Grant Accelerated Approval to Aducanumab for Alzheimer's Disease.
Dhruva SS, Kesselheim AS, Woloshin S, Ji RZ, Lu Z, Darrow JJ, Redberg RF
Clin Pharmacol Ther. 2023 Sep;114(3):614-617. doi: 10.1002/cpt.2954. Epub 2023 Jun 7.
PMID: 37218658

Communicating health information with visual displays.
Woloshin S, Yang Y, Fischhoff B
Nat Med. 2023 May;29(5):1085-1091. doi: 10.1038/s41591-023-02328-1. Epub 2023 May 8.
PMID: 37156935

Direct-to-Consumer Low-Testosterone Clinics-Where Is the Federation of State Medical Boards?
Woloshin S, Gill LL
JAMA Intern Med. 2023 Apr 1;183(4):288-289. doi: 10.1001/jamainternmed.2022.7008.
PMID: 36804766

Association between tobacco product use and asthma among US adults from the Population Assessment of Tobacco and Health (PATH) Study waves 2-4.
Brunette MF, Halenar MJ, Edwards KC, Taylor KA, Emond JA, Tanski SE, Woloshin S, Paulin LM, Hyland A, Lauten K, Mahoney M, Blanco C, Borek N, DaSilva LC, Gardner LD, Kimmel HL, Sargent JD
BMJ Open Respir Res. 2023 Feb;10(1) doi: 10.1136/bmjresp-2021-001187.
PMID: 36750276

Therapeutic Value of Drugs Frequently Marketed Using Direct-to-Consumer Television Advertising, 2015 to 2021.
Patel NG, Hwang TJ, Woloshin S, Kesselheim AS
JAMA Netw Open. 2023 Jan 3;6(1):e2250991. doi: 10.1001/jamanetworkopen.2022.50991. Epub 2023 Jan 3.
PMID: 36637824

Cancer overdiagnosis: a challenge in the era of screening.
Dunn BK, Woloshin S, Xie H, Kramer BS
J Natl Cancer Cent. 2022 Dec;2(4):235-242. doi: 10.1016/j.jncc.2022.08.005. Epub 2022 Aug 21.
PMID: 36568283

View more publications on PubMed